Broadcom Stock Slips Despite Earnings Beat

The stock hit a record high yesterday

by Lillian Currens

Published on Dec 13, 2019 at 9:39 AM

Broadcom Inc (NASDAQ:AVGO) is falling from yesterday's record peak of $330.16, despite posting a fourth-quarter earnings beat of $5.39 per share. The semiconductor concern also lifted its revenue forecast above expectations, but Wall Street remains grim toward the equity, as growth in the semiconductor industry continues to slow. At last check, AVGO is down 1.5% at $322.90. 

A round of bull notes couldn't sway investors either. No fewer than eight brokerages hiked their price targets, including Craig-Hallum, which lifted its estimate to a street high of $385 from $330. What's more, RBC reinstated coverage with an "outperform" rating, and a $360 price target. The consensus 12-month price target is now at $340.82 -- slightly north of current levels. Prior to today, 16 of those in coverage called AVGO a "buy" or better, while four called it a "hold."

This bullishness among the brokerage bunch shouldn't be surprising. As we previously mentioned, AVGO snapped up a new high just yesterday, and it's been an impressive run on the charts these past few months, with recent support emerging at the ascending 30-day moving average. For the year, Broadcom stock has added 28%. 

Regardless, in the options pits, short-term players haven't been more put-heavy. The stock's Schaeffer's open interest ratio (SOIR) of 1.30 sits in the 88th percentile of its annual range.


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


IRA/401k: The Crash-Proof Retirement Plan
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.
Patent Lawsuit Loss Sends AMRN Stock Spiraling
Amarin just lost a major U.S. patent lawsuit for its heart drug Vascepa
RH Stock Sinks Despite Earnings Beat
J.P. Morgan Securities and Cowen and Company cut their price targets
IRA/401k: The Crash-Proof Retirement Plan
Use gold to protect any IRA, 401(k), or retirement account from a looming financial crisis.